RSS-Feed abonnieren
DOI: 10.1055/s-0037-1609112
Synthesis of a PCSK9 Inhibitor
A Scalable Route for the Regio- and Enantioselective Preparation of a Tetrazole Prodrug: Application to the Multi-Gram-Scale Synthesis of a PCSK9 Inhibitor.
Org. Process Res. Dev. 2017;
21: 1990-2000
Publikationsverlauf
Publikationsdatum:
15. Februar 2018 (online)
Key words
PCSK9 inhibitor - tetrazole ring formation - organocatalysis - Negishi coupling - asymmetric hemiaminal ester formation![](https://www.thieme-connect.de/media/synfacts/201803/i_k003_s1_10-1055_s-0037-1609112.gif)
Significance
The target molecule I is a hemiaminal ester prodrug of an inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9) that is of interest for reducing serum LDL-cholesterol levels. A markworthy step in the synthesis depicted is the three-component dynamic kinetic resolution between tetrazole D, acetaldehyde, and isobutyric anhydride catalyzed by the enantiopure DMAP catalyst E to afford hemiaminal ester (S)-F (er = 97:3) in quantitative yield on a multikilogram scale.
#
Comment
The tetrazole D was initially generated by reaction of nitrile C with hydrazoic acid generated in situ from sodium azide and ammonium chloride in DMF at >100 °C. This method generates toxic and explosive anhydrous hydrazoic acid (pK a = 4.6). A safer method shown here for the synthesis of D entails reaction of sodium azide (2 equiv) with nitrile C using zinc bromide (0.1 equiv) as a catalyst in isopropanol–water (1:1) at 75 °C. Under these conditions only trace amounts of hydrazoic acid are generated. The yield is 85%.
#
#
![](https://www.thieme-connect.de/media/synfacts/201803/i_k003_s1_10-1055_s-0037-1609112.gif)